Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

A single intrathecal injection of DNA and an asymmetric cationic lipid as lipoplexes ameliorates experimental autoimmune encephalomyelitis.

Yellayi S, Hilliard B, Ghazanfar M, Tsingalia A, Nantz MH, Bollinger L, de Kok-Mercado F, Hecker JG.

Mol Pharm. 2011 Oct 3;8(5):1980-4. doi: 10.1021/mp2002413. Epub 2011 Jul 19.

2.

Whole animal in vivo imaging after transient, nonviral gene delivery to the rat central nervous system.

Hauck ES, Zou S, Scarfo K, Nantz MH, Hecker JG.

Mol Ther. 2008 Nov;16(11):1857-64. doi: 10.1038/mt.2008.183. Epub 2008 Aug 26.

3.

HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.

Furlan R, Bergami A, Brambilla E, Butti E, De Simoni MG, Campagnoli M, Marconi P, Comi G, Martino G.

Gene Ther. 2007 Jan;14(1):93-8. Epub 2006 Aug 24.

PMID:
16929354
4.

Intrathecal administration of neutralizing antibody against Fas ligand suppresses the progression of experimental autoimmune encephalomyelitis.

Okuda Y, Sakoda S, Fujimura H, Nagata S, Yanagihara T, Bernard CC.

Biochem Biophys Res Commun. 2000 Aug 18;275(1):164-8.

PMID:
10944459
5.

TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice.

Cretney E, McQualter JL, Kayagaki N, Yagita H, Bernard CC, Grewal IS, Ashkenazi A, Smyth MJ.

Immunol Cell Biol. 2005 Oct;83(5):511-9.

PMID:
16174101
6.

Gene-based delivery of IFN-beta is efficacious in a murine model of experimental allergic encephalomyelitis.

Schaefer C, Hidalgo TR, Cashion L, Petry H, Brooks A, Szymanski P, Qian HS, Gross C, Wang P, Liu P, Goldman C, Rubanyi GM, Harkins RN.

J Interferon Cytokine Res. 2006 Jul;26(7):449-54.

PMID:
16800783
7.

Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14·TRAIL.

Prinz-Hadad H, Mizrachi T, Irony-Tur-Sinai M, Prigozhina TB, Aronin A, Brenner T, Dranitzki-Elhalel M.

J Neuroinflammation. 2013 Mar 9;10:36. doi: 10.1186/1742-2094-10-36.

8.

Gene expression along the cerebral-spinal axis after regional gene delivery.

Meuli-Simmen C, Liu Y, Yeo TT, Liggitt D, Tu G, Yang T, Meuli M, Knauer S, Heath TD, Longo FM, Debs RJ.

Hum Gene Ther. 1999 Nov 1;10(16):2689-700.

PMID:
10566897
9.

Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis.

Hilliard B, Wilmen A, Seidel C, Liu TS, Göke R, Chen Y.

J Immunol. 2001 Jan 15;166(2):1314-9.

10.

Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.

Hu X, Qin X.

Int J Mol Med. 2013 May;31(5):1209-21. doi: 10.3892/ijmm.2013.1306. Epub 2013 Mar 15.

PMID:
23525227
11.

CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery.

Fransson M, Piras E, Burman J, Nilsson B, Essand M, Lu B, Harris RA, Magnusson PU, Brittebo E, Loskog AS.

J Neuroinflammation. 2012 May 30;9:112. doi: 10.1186/1742-2094-9-112.

12.

In vivo administration of plasmid DNA encoding recombinant immunotoxin DT390-IP-10 attenuates experimental autoimmune encephalomyelitis.

Chen W, Li H, Jia Y, Lv M, Li M, Feng P, Hu H, Zhang L.

J Autoimmun. 2007 Feb;28(1):30-40. Epub 2007 Jan 30.

PMID:
17267177
13.

Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle.

Makar TK, Bever CT, Singh IS, Royal W, Sahu SN, Sura TP, Sultana S, Sura KT, Patel N, Dhib-Jalbut S, Trisler D.

J Neuroimmunol. 2009 May 29;210(1-2):40-51. doi: 10.1016/j.jneuroim.2009.02.017. Epub 2009 Apr 10.

PMID:
19361871
14.

Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein.

Columba-Cabezas S, Griguoli M, Rosicarelli B, Magliozzi R, Ria F, Serafini B, Aloisi F.

J Neuroimmunol. 2006 Oct;179(1-2):76-86. Epub 2006 Jul 25.

PMID:
16870269
15.

Fn14-TRAIL, a chimeric intercellular signal exchanger, attenuates experimental autoimmune encephalomyelitis.

Razmara M, Hilliard B, Ziarani AK, Murali R, Yellayi S, Ghazanfar M, Chen YH, Tykocinski ML.

Am J Pathol. 2009 Feb;174(2):460-74. doi: 10.2353/ajpath.2009.080462. Epub 2009 Jan 15.

16.

Local gene therapy with CTLA4-immunoglobulin fusion protein in experimental allergic encephalomyelitis.

Croxford JL, O'Neill JK, Ali RR, Browne K, Byrnes AP, Dallman MJ, Wood MJ, Fedlmann M, Baker D.

Eur J Immunol. 1998 Dec;28(12):3904-16.

17.
18.

Gene-based intramuscular interferon-beta therapy for experimental autoimmune encephalomyelitis.

Jaini R, Hannaman D, Johnson JM, Bernard RM, Altuntas CZ, Delasalas MM, Kesaraju P, Luxembourg A, Evans CF, Tuohy VK.

Mol Ther. 2006 Sep;14(3):416-22. Epub 2006 Jun 16.

19.

Liposomal lipid and plasmid DNA delivery to B16/BL6 tumors after intraperitoneal administration of cationic liposome DNA aggregates.

Reimer DL, Kong S, Monck M, Wyles J, Tam P, Wasan EK, Bally MB.

J Pharmacol Exp Ther. 1999 May;289(2):807-15.

20.

Supplemental Content

Support Center